中國農產品交易(00149.HK):7.93億股要約股份獲有效接納 部分要約截止
格隆匯2月12日丨中國農產品交易(00149.HK)公佈,部分要約於2020年2月12日截止。於本聯合公佈日期,已接獲來自金利豐證券根據金利豐不可撤銷承諾就7.93億股股份(佔於本聯合公佈日期已發行股份約7.97%)的有效接納。
於本聯合公佈日期下午四時正,要約人已接獲來自獨立股東於部分股份要約項下就57.04億股股份(佔於本聯合公佈日期已發行股份約57.31%)的有效接納;及部分可換股票據要約項下概無有效接納。
於結算部分股份要約後,26.33億股股份將由公眾持有(佔於本聯合公佈日期已發行股份約26.45%)。因此,中國農產品將能符合上市規則第8.08條的公眾持股量規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.